{"Symbol": "ILMN", "AssetType": "Common Stock", "Name": "Illumina Inc", "Description": "Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.", "CIK": "1110803", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "LABORATORY ANALYTICAL INSTRUMENTS", "Address": "5200 ILLUMINA WAY, SAN DIEGO, CA, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "59243954000", "EBITDA": "918000000", "PERatio": "62.05", "PEGRatio": "2.989", "BookValue": "67.47", "DividendPerShare": "None", "DividendYield": "0", "EPS": "6.11", "RevenuePerShareTTM": "28.97", "ProfitMargin": "0.212", "OperatingMarginTTM": "0.165", "ReturnOnAssetsTTM": "0.0393", "ReturnOnEquityTTM": "0.119", "RevenueTTM": "4280000000", "GrossProfitTTM": "2231000000", "DilutedEPSTTM": "6.11", "QuarterlyEarningsGrowthYOY": "0.719", "QuarterlyRevenueGrowthYOY": "0.395", "AnalystTargetPrice": "438.69", "TrailingPE": "62.05", "ForwardPE": "93.46", "PriceToSalesRatioTTM": "13.84", "PriceToBookRatio": "5.6", "EVToRevenue": "14.15", "EVToEBITDA": "44.11", "Beta": "0.86", "52WeekHigh": "555.77", "52WeekLow": "301.73", "50DayMovingAverage": "410.79", "200DayMovingAverage": "433.73", "SharesOutstanding": "156300000", "DividendDate": "None", "ExDividendDate": "None"}